Cargando…

Correction: ERCC2 gene single-nucleotide polymorphism as a prognostic factor for locally advanced head and neck carcinomas after definitive cisplatin-based radiochemotherapy

Detalles Bibliográficos
Autores principales:	Guberina, Maja, Sak, Ali, Pöttgen, Christoph, Tinhofer-Keilholz, Ingeborg, Budach, Volker, Balermpas, Panagiotis, Von der Grün, Jens, Rödel, Claus Michael, Gkika, Eleni, Grosu, Anca-Ligia, Abdollahi, Amir, Debus, Jürgen, Belka, Claus, Pigorsch, Steffi, Combs, Stephanie E., Mönnich, David, Zips, Daniel, De-Colle, Chiara, Welz, Stefan, Linge, Annett, Lohaus, Fabian, Baretton, Gustavo, Gauler, Thomas, Baumann, Michael, Krause, Mechthild, Schuler, Martin, Bankfalvi, Agnes, Höing, Benedikt, Lang, Stephan, Stuschke, Martin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7997801/ https://www.ncbi.nlm.nih.gov/pubmed/33009516 http://dx.doi.org/10.1038/s41397-020-00193-6

Ejemplares similares

ERCC2 gene single-nucleotide polymorphism as a prognostic factor for locally advanced head and neck carcinomas after definitive cisplatin-based radiochemotherapy
por: Guberina, Maja, et al.
Publicado: (2020)

SDF-1/CXCR4 expression in head and neck cancer and outcome after postoperative radiochemotherapy
por: De-Colle, Chiara, et al.
Publicado: (2017)

Heat shock protein 70 and tumor‐infiltrating NK cells as prognostic indicators for patients with squamous cell carcinoma of the head and neck after radiochemotherapy: A multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group (DKTK‐ROG)
por: Stangl, Stefan, et al.
Publicado: (2017)

A comparative study of machine learning methods for time-to-event survival data for radiomics risk modelling
por: Leger, Stefan, et al.
Publicado: (2017)

Comparison of the composition of lymphocyte subpopulations in non-relapse and relapse patients with squamous cell carcinoma of the head and neck before, during radiochemotherapy and in the follow-up period: a multicenter prospective study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG)
por: Niu, Minli, et al.
Publicado: (2021)

A Novel 2-Metagene Signature to Identify High-Risk HNSCC Patients amongst Those Who Are Clinically at Intermediate Risk and Are Treated with PORT
por: Patil, Shivaprasad, et al.
Publicado: (2022)

Integrated radiogenomics analyses allow for subtype classification and improved outcome prognosis of patients with locally advanced HNSCC
por: Rabasco Meneghetti, Asier, et al.
Publicado: (2022)

DNA-Methylome–Based Tumor Hypoxia Classifier Identifies HPV-Negative Head and Neck Cancer Patients at Risk for Locoregional Recurrence after Primary Radiochemotherapy
por: Tawk, Bouchra, et al.
Publicado: (2023)

Multitask Learning with Convolutional Neural Networks and Vision Transformers Can Improve Outcome Prediction for Head and Neck Cancer Patients
por: Starke, Sebastian, et al.
Publicado: (2023)

Comprehensive Analysis of Tumour Sub-Volumes for Radiomic Risk Modelling in Locally Advanced HNSCC
por: Leger, Stefan, et al.
Publicado: (2020)

Long-term survival of patients with central or > 7 cm T4 N0/1 M0 non-small-cell lung cancer treated with definitive concurrent radiochemotherapy in comparison to trimodality treatment
por: Guberina, Nika, et al.
Publicado: (2022)

2D and 3D convolutional neural networks for outcome modelling of locally advanced head and neck squamous cell carcinoma
por: Starke, Sebastian, et al.
Publicado: (2020)

Prognostic model for long-term survival of locally advanced non-small-cell lung cancer patients after neoadjuvant radiochemotherapy and resection integrating clinical and histopathologic factors
por: Pöttgen, Christoph, et al.
Publicado: (2015)

Independent validation of tumour volume, cancer stem cell markers and hypoxia-associated gene expressions for HNSCC after primary radiochemotherapy
por: Linge, Annett, et al.
Publicado: (2019)

Respiration-controlled radiotherapy in lung cancer: Systematic evaluation of the optimal application practice
por: Guberina, M., et al.
Publicado: (2023)

Impact of EBUS-TBNA in addition to [(18)F]FDG-PET/CT imaging on target volume definition for radiochemotherapy in stage III NSCLC
por: Guberina, Maja, et al.
Publicado: (2021)

Dynamics of HMBG1 (High Mobility Group Box 1) during radiochemotherapy correlate with outcome of HNSCC patients
por: Clasen, Kerstin, et al.
Publicado: (2021)

RADIANCE – Radiochemotherapy with or without Durvalumab in the treatment of anal squamous cell carcinoma: A randomized multicenter phase II trial
por: Martin, Daniel, et al.
Publicado: (2020)

Fractionation versus Adaptation for Compensation of Target Volume Changes during Online Adaptive Radiotherapy for Bladder Cancer: Answers from a Prospective Registry
por: Pöttgen, Christoph, et al.
Publicado: (2023)

Radiotherapy and "new" drugs-new side effects?
por: Niyazi, Maximilian, et al.
Publicado: (2011)

Plasma sICAM-1 Correlates with Tumor Volume Before Primary Radiochemotherapy of Head and Neck Squamous Cell Carcinoma Patients
por: Clasen, Kerstin, et al.
Publicado: (2022)

Resolution of atelectasis during radiochemotherapy of lung cancer with serious implications for further treatment. A case report
por: Braun, Lore Helene, et al.
Publicado: (2017)

Targeted Therapies and Immune-Checkpoint Inhibition in Head and Neck Squamous Cell Carcinoma: Where Do We Stand Today and Where to Go?
por: von der Grün, Jens, et al.
Publicado: (2019)

Diagnostic and treatment modalities for patients with cervical lymph node metastases of unknown primary site – current status and challenges
por: Müller von der Grün, Jens, et al.
Publicado: (2017)

Definitive radiochemotherapy versus surgery within multimodality treatment in stage III non-small cell lung cancer (NSCLC) - a cumulative meta-analysis of the randomized evidence
por: Pöttgen, Christoph, et al.
Publicado: (2017)

The rationale for including immune checkpoint inhibition into multimodal primary treatment concepts of head and neck cancer
por: Tinhofer, Ingeborg, et al.
Publicado: (2016)

Chemoradiotherapy as Definitive Treatment for Elderly Patients with Head and Neck Cancer
por: Müller von der Grün, Jens, et al.
Publicado: (2018)

Patterns of care analysis for salivary gland cancer: a survey within the German Society of Radiation Oncology (DEGRO) and recommendations for daily practice
por: von der Grün, Jens, et al.
Publicado: (2021)

Dose-escalated radiotherapy with PET/CT based treatment planning in combination with induction and concurrent chemotherapy in locally advanced (uT3/T4) squamous cell cancer of the esophagus: mature results of a phase I/II trial
por: Pöttgen, C., et al.
Publicado: (2021)

Kein Vorteil für die lokale Kontrolle nach Dosiseskalation der Strahlentherapie bei Patienten mit Ösophaguskarzinom nach einer definitiven Radiochemotherapie: randomisierte Phase-III-Studie ARTDECO
por: Fokas, Emmanouil, et al.
Publicado: (2022)

Comparison of Online-Onboard Adaptive Intensity-Modulated Radiation Therapy or Volumetric-Modulated Arc Radiotherapy With Image-Guided Radiotherapy for Patients With Gynecologic Tumors in Dependence on Fractionation and the Planning Target Volume Margin
por: Guberina, Maja, et al.
Publicado: (2023)

Merkel Cell Polyoma Viral Load and Intratumoral CD8+ Lymphocyte Infiltration Predict Overall Survival in Patients With Merkel Cell Carcinoma
por: von der Grün, Jens, et al.
Publicado: (2019)

Independent validation of the prognostic value of cancer stem cell marker expression and hypoxia-induced gene expression for patients with locally advanced HNSCC after postoperative radiotherapy
por: Linge, Annett, et al.
Publicado: (2016)

Peripheral Leukocytosis Is Inversely Correlated with Intratumoral CD8+ T-Cell Infiltration and Associated with Worse Outcome after Chemoradiotherapy in Anal Cancer
por: Martin, Daniel, et al.
Publicado: (2017)

C-Reactive Protein-to-Albumin Ratio as Prognostic Marker for Anal Squamous Cell Carcinoma Treated With Chemoradiotherapy
por: Martin, Daniel, et al.
Publicado: (2019)

Re‐irradiation of recurrent gliomas: pooled analysis and validation of an established prognostic score—report of the Radiation Oncology Group (ROG) of the German Cancer Consortium (DKTK)
por: Combs, Stephanie E., et al.
Publicado: (2018)

Phase II trial of preoperative radiochemotherapy with concurrent bevacizumab, capecitabine and oxaliplatin in patients with locally advanced rectal cancer
por: Dellas, Kathrin, et al.
Publicado: (2013)

Spatial and dosimetric evaluation of residual distortions of prostate and seminal vesicle bed after image‐guided definitive and postoperative radiotherapy of prostate cancer with endorectal balloon
por: Levegrün, Sabine, et al.
Publicado: (2020)

Dosimetric impact of the positioning variation of tumor treating field electrodes in the PriCoTTF‐phase I/II trial
por: Nour, Youness, et al.
Publicado: (2021)

Re-irradiation with concurrent and maintenance nivolumab in locally recurrent and inoperable squamous cell carcinoma of the head and neck: A single-center cohort study
por: Altay-Langguth, Alev, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_bcqiesfa9b6tte3bfgphikgv7g